stella
beta
IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes — Stella
Home
/
Intracranial Aneurysm
/
IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes
View on ClinicalTrials.gov
Recruiting
Back to Intracranial Aneurysm trials
IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(21 sites)
China
The First Affiliated Hospital of University of Science and Technology of China, Hefei, Anhui
The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui
Guizhou Provincial People's Hospital, Guiyang, Guizhou
First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan
Shiyan People's Hospital, Shiyan, Hubei
Research Institute Of Medical Imaging Jinling Hospital, Nanjing, Jiangsu
Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu
The First Hospital of Jilin University, Changchun, Jilin
Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong
Yidu Central Hospital Affiliated to Shandong Second Medical University, Weifang, Shandong
The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan
Hainan General Hospital, Haikou
The First People's Hospital of Kashgar Region, Kashgar
University Second Hospital, Lanzhou
First People's Hospital of Lianyungang, Lianyungang
Ma'anshan People's Hospital, Ma’anshan
BenQ Medical Center, Affiliated BenQ Hospital of Medical School, Nanjing Medical University, Nanjing
Long Gang Central Hospital of Shenzhen, Shenzhen
The Affiliated Suqian First Hospital of Nanjing Medical University, Suqian
Tianjin Medical University General Hospital, Tianjin
General Hospital of Ningxia Medical University, Yinchuan